New data on Crohn’s disease presented at Digestive Disease Week in Chicago

New studies show that patients with moderate to severe Crohn’s disease can maintain remission through three years of therapy with adalimumab (HUMIRA®).  It appears that not only has adalimumab demonstrated its efficacy at the beginning of the treatment but it has also shown to maintain its effectiveness over the long-term - pretty important when considering how to manage a chronic condition like Crohn’s disease.

A secondary analysis of the same study demonstrated that patients being treated with adalimumab for Crohn's disease may also be able to achieve long-term steroid-free remission.

A disease of long duration generally involving slow changes. Full medical glossary
Myocardial infarction. Death of a segment of heart muscle, which follows interruption of its blood supply. Full medical glossary
rheumatoid arthritis Full medical glossary
The lessening or disappearance of the symptoms or signs of a disease. Full medical glossary